Company page
Bioatla, Inc.
Bioatla, Inc. is a public company traded under the ticker BCAB in the American market. The company has a market capitalization of approximately $6.07 million. Bioatla focuses on developing innovative therapies for cancer treatment.
- Ticker
- BCAB:NASDAQ
- Asset type
- Stock
- Market cap
- $6.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD